Kimberly Y Smith Selected Research

Kimberly Y Smith Research Topics

15	Infections 01/2022 - 09/2002
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2019 - 07/2012
5	Injection Site Reaction 12/2021 - 01/2017
4	HIV Infections (HIV Infection) 12/2021 - 03/2008
3	Pain (Aches) 01/2020 - 01/2017
2	Nausea 12/2017 - 07/2012
1	Fatigue 11/2021
1	Hepatitis B 01/2018
1	Headache (Headaches) 12/2017
1	Hepatitis C 12/2013
1	Exanthema (Rash) 07/2012
1	Diarrhea 07/2012
1	Tetanus 09/2002
1	Coronary Artery Disease (Coronary Atherosclerosis) 06/2002
1	Hyperlipidemias (Hyperlipidemia) 06/2002
1	Dyslipidemias (Dyslipidemia) 02/2002

10	cabotegravirIBA 12/2021 - 10/2015
8	Rilpivirine (TMC-278)IBA 12/2021 - 10/2015
6	dolutegravirIBA 01/2022 - 12/2017
5	Lamivudine (Epivir)FDA Link 01/2022 - 12/2017
4	Emtricitabine (Emtriva)FDA Link 12/2021 - 03/2008
4	Tenofovir (Viread)FDA Link 12/2021 - 03/2008
4	Atazanavir Sulfate (Reyataz)FDA Link 01/2019 - 03/2008
4	Ritonavir (Norvir)FDA Link 01/2019 - 03/2008
3	IntegrasesIBA 12/2021 - 12/2017
3	RNA (Ribonucleic Acid)IBA 01/2019 - 12/2013
2	lamivudine drug combination abacavir FDA Link 01/2020 - 01/2019
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2019 - 06/2002
2	efavirenz (Sustiva)FDA Link 01/2019 - 12/2017
1	RacivirIBA 12/2021
1	Maraviroc FDA Link 01/2019
1	Cytochrome P-450 CYP3AIBA 01/2019
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	abacavir (Ziagen)FDA Link 12/2017
1	Antiviral Agents (Antivirals)IBA 01/2017
1	Human immunodeficiency virus 1 p31 integrase proteinIBA 01/2017
1	Reverse Transcriptase InhibitorsIBA 10/2015
1	NucleosidesIBA 10/2015
1	Pharmaceutical PreparationsIBA 10/2015
1	Darunavir (Prezista)FDA Link 07/2012
1	fosamprenavir (Lexiva)FDA Link 03/2008
1	AntigensIBA 09/2002
1	red yeast riceIBA 02/2002

9	Therapeutics 01/2022 - 06/2002
7	Injections 12/2021 - 10/2015
1	Highly Active Antiretroviral Therapy (HAART) 09/2002